title: Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
authors.affiliation: Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada. Electronic address: itheb007@uottawa.ca.
authors.forename: I
authors.initials: I
authors.lastname: Theberge
authors.affiliation: Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Bowdridge
authors.affiliation: Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
authors.forename: M A
authors.initials: MA
authors.lastname: Forgie
authors.affiliation: Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Carrier
authors.affiliation: Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Louzada
authors.affiliation: Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
authors.forename: L
authors.initials: L
authors.lastname: Siquiera
authors.affiliation: Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Rhodes
authors.affiliation: Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada. Electronic address: pwells@toh.ca.
authors.forename: P S
authors.initials: PS
authors.lastname: Wells
mesh_terms: D065427:Factor Xa Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000069552:Rivaroxaban / Q000494:pharmacology / Q000627:therapeutic use*; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000473:pathology
chemical_list: D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban